European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 283, P. 117152 - 117152
Published: Dec. 8, 2024
Language: Английский
European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 283, P. 117152 - 117152
Published: Dec. 8, 2024
Language: Английский
Molecular Immunology, Journal Year: 2025, Volume and Issue: 178, P. 1 - 11
Published: Jan. 6, 2025
Language: Английский
Citations
0Microbial Pathogenesis, Journal Year: 2025, Volume and Issue: unknown, P. 107364 - 107364
Published: Feb. 1, 2025
Language: Английский
Citations
0Phytomedicine, Journal Year: 2025, Volume and Issue: 140, P. 156609 - 156609
Published: March 7, 2025
Language: Английский
Citations
0International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(9), P. 4325 - 4325
Published: May 2, 2025
Severe dental pulp inflammation can lead to tissue lysis and destruction, underscoring the necessity for effective treatment of pulpitis. N-acetyltransferase 10 (NAT10)-mediated N4-acetylcytidine (ac4C) modification has recently emerged as a key regulator in inflammatory processes. However, whether NAT10 affects response human stem cells (hDPSCs) remains unelucidated. In this study, elevated expression was observed pulpitis tissues LPS-stimulated hDPSCs. Knockdown led reduced gene lower reactive oxygen species (ROS) production hDPSCs, while chemotactic migration macrophages also suppressed. Similar results were when hDPSCs treated with Remodelin, an inhibitor NAT10. Differentially expressed genes identified through RNA sequencing significantly enriched signaling pathways after depletion. Among differential genes, pentraxins 3 (PTX3) potential target due presence ac4C site its known ability regulate inflammation. The mRNA protein levels PTX3 NAT10-deficient cells, along decrease stability. Exogenous supplementation partially reversed inhibition induced by knockdown. Further evidence vivo revealed that Remodelin attenuated severity rats summary, these data indicated deficiency inhibited stability further hDPSC inflammation, might be therapeutic agent capping.
Language: Английский
Citations
0European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 283, P. 117152 - 117152
Published: Dec. 8, 2024
Language: Английский
Citations
2